Skip to main content

Imago BioSciences, Inc.

IMGODelisted Jan 11, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001623715

Imago BioSciences, Inc. was delisted on Jan 11, 2023; its insiders filed their last Form 4 on Jan 11, 2023; 106 institutions reported holding it in 13F filings for Q4 2022, worth $1.05B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Imago BioSciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of IMGO: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3952+13
Shares23.8M25.7M+1.87M (+7.8%)
Value$473.1M$606.7M+$133.6M (+28.2%)

New holders (14)

Institutions that held Imago BioSciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to IMGO in Q4 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC151,786$3.60M0.00%
Parkman Healthcare Partners LLC110,000$2.61M0.59%
Goldman Sachs Group Inc87,762$2.08M0.00%
HRT Financial LP65,989$1.56M0.01%
Alps Advisors Inc38,802$920.0K0.01%
D. E. Shaw & Co., Inc.32,058$760.0K0.00%
Swiss National Bank25,800$612.0K0.00%
Ensign Peak Advisors, Inc25,000$593.0K0.00%
Susquehanna International Group, LLP14,137$335.0K0.00%
Squarepoint Ops LLC11,305$268.0K0.00%
Virtus ETF Advisers LLC9,065$215.0K0.08%
New York State Common Retirement Fund6,482$154.0K0.00%
Allspring Global Investments Holdings, LLC3,967$94.0K0.00%
Daiwa Securities Group Inc.98$2.00K0.00%

Sold out (1)

Institutions that held Imago BioSciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of IMGO in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Perceptive Advisors LLC125,000$2.50M